Terazosin Impurities and its Related Products



Displaying 13 results of Terazosin Impurities

Terazosin is a medication used to treat high blood pressure and symptoms of an enlarged prostate. However, the manufacturing process of terazosin may result in the presence of impurities, which are unwanted substances that can affect the purity, potency, and safety of the drug. These impurities may include related compounds, degradation products, and residual solvents. The identification and quantification of terazosin impurities are important for ensuring the quality and efficacy of the medication.
COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
(4-(4-amino-7-hydroxy-6-methoxyquinazolin-2-yl)piperazin-1-y... Impurities CS-O-42124 Not Available Enquire
[4-(4-Amino-6-hydroxy-7-methoxy-2-quinazolinyl)-1-piperaziny... Impurities CS-T-02748 105356-89-6 Enquire
N-Nitroso Terazosin EP Impurity N Impurities CS-O-43974 2470438-57-2 In Stock
Terazosin EP Impurity B Impurities CS-O-08279 1177261-73-2 In Stock
Terazosin EP Impurity C Impurities CS-T-40082 60547-97-9 In Stock
Terazosin EP Impurity D Impurities CS-O-08281 102714-74-9 In Stock
Terazosin EP Impurity E Impurities CS-O-08282 104965-50-6 (Hydrochloride Salt) Enquire
Terazosin EP Impurity H Impurities CS-T-02750 105356-90-9 Enquire
Terazosin EP Impurity P Impurities CS-O-54662 2470437-02-4 Enquire
Terazosin impurity Impurities CS-O-42230 21575-27-9 Enquire
Terazosin Impurity 6 Impurities CS-O-43975 393124-28-2 In Stock
Terazosin related compound A Impurities CS-P-00203 60548-08-5 In Stock
Terazosin related compound C Impurities CS-P-00204 1486464-41-8 In Stock